BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3986169)

  • 1. Correlation between cytoplasmic steroid receptors and tumour differentiation and invasion in endometrial carcinoma.
    Quinn MA; Pearce P; Fortune DW; Koh SH; Hsieh C; Cauchi M
    Br J Obstet Gynaecol; 1985 Apr; 92(4):399-406. PubMed ID: 3986169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
    Utaaker E; Iversen OE; Skaarland E
    Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium.
    Tamaya T; Fujimoto J; Okada H
    Acta Obstet Gynecol Scand; 1985; 64(4):307-9. PubMed ID: 4024879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between the levels of estrogen receptor and progesterone receptor and clinicopathological status in human endometrial carcinomas].
    Yi X; Yao X
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Mar; 22(1):66-9. PubMed ID: 1774041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium.
    Geisinger KR; Marshall RB; Kute TE; Homesley HD
    Cancer; 1986 Oct; 58(7):1506-17. PubMed ID: 3742469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
    Hatae M; Yagi Y
    Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic steroid receptors in ovarian tumours.
    Quinn MA; Pearce P; Rome R; Funder JW; Fortune D; Pepperell RJ
    Br J Obstet Gynaecol; 1982 Sep; 89(9):754-9. PubMed ID: 7115640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival.
    Slotman BJ; Kühnel R; Rao BR; Dijkhuizen GH; de Graaff J; Stolk JG
    Gynecol Oncol; 1989 Apr; 33(1):76-81. PubMed ID: 2703171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On receptors for estrogens (E2) and androgens (DHT) in human endometrial carcinoma and ovarian tumours.
    Friberg LG; Kullander S; Persijn JP; Korsten CB
    Acta Obstet Gynecol Scand; 1978; 57(3):261-4. PubMed ID: 665172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].
    Bassalyk LS; Petrova AS; Ermilova VD; Sokolova VK; Kushlinskiĭ NE
    Arkh Patol; 1983; 45(2):23-8. PubMed ID: 6847409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
    Ciocca DR; Puy LA; Fasoli LC
    Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is endocrine status relevant to treatment planning in patients with gynaecological cancer?
    Quinn MA
    Aust N Z J Obstet Gynaecol; 1984 May; 24(2):153-7. PubMed ID: 6594131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of androgen receptors with histological differentiation in human endometrial carcinomas.
    Kato J; Seto T
    Acta Obstet Gynecol Scand; 1985; 64(3):209-12. PubMed ID: 3874514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE; Young PC; Cleary RE
    Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroid receptors in normal and hyperplastic human prostate.
    Robel P; Eychenne B; Blondeau JP; Baulieu EE; Hechter O
    Prostate; 1985; 6(3):255-67. PubMed ID: 2581236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.